Eli Lilly shares slip despite earnings beat
April 24, 2018 at 07:03 AM EDT
A Food and Drug Administration advisory committee voted Monday against approving a higher dose of Lilly and Incyte's rheumatoid arthritis drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.